$BKSY
BlackSky Technology Inc.

2020 Form 10-K Financial Statement

#000119312521100894 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $23.87M $11.50M
YoY Change 107.58%
Gross Profit -$2.731M $2.216M
YoY Change -223.24%
Gross Profit Margin
Selling, General & Admin $28.61M $264.4K
YoY Change 10721.26% 12026.15%
% of Gross Profit 11.93%
Research & Development $255.0K $1.099M
YoY Change -76.8%
% of Gross Profit 49.59%
Depreciation & Amortization $9.803M $6.897M
YoY Change 42.13%
% of Gross Profit 311.24%
Operating Expenses $28.86M $264.3K
YoY Change 10818.14% 12025.69%
Operating Profit -$41.40M -$264.3K
YoY Change 15559.4% 12042.67%
Interest Expense $5.201M $708.5K
YoY Change 634.08%
% of Operating Profit
Other Income/Expense, Net $1.797M $708.5K
YoY Change 153.64%
Pretax Income -$47.72M $444.2K
YoY Change -10843.68% -20502.76%
Income Tax $0.00 $93.28K
% Of Pretax Income 21.0%
Net Earnings -$19.54M $350.9K
YoY Change -5667.22% -16218.19%
Net Earnings / Revenue
Basic Earnings Per Share -$0.60
Diluted Earnings Per Share -$0.60 -$200.6K
COMMON SHARES
Basic Shares Outstanding 33.01M shares 39.53M
Diluted Shares Outstanding 33.01M shares

Balance Sheet

Concept 2020 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $399.5K $1.084M
YoY Change -63.13% 2476.34%
Cash & Equivalents $5.098M $37.19M $31.72M
Short-Term Investments
Other Short-Term Assets $345.8K $202.5K
YoY Change 70.79%
Inventory
Prepaid Expenses $202.5K
Receivables $6.699M $4.328M
Other Receivables $0.00 $0.00
Total Short-Term Assets $745.3K $1.286M $1.286M
YoY Change -42.05% 2957.66% 2957.73%
LONG-TERM ASSETS
Property, Plant & Equipment $20.85M $11.68M
YoY Change 78.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $318.0M $317.0M
YoY Change 0.34%
Other Assets $0.00 $1.360K
YoY Change -100.0% -99.21%
Total Long-Term Assets $318.0M $317.0M $317.0M
YoY Change 0.34% 183882.7% 183879.5%
TOTAL ASSETS
Total Short-Term Assets $745.3K $1.286M $1.286M
Total Long-Term Assets $318.0M $317.0M $317.0M
Total Assets $318.8M $318.2M $318.2M
YoY Change 0.17% 148378.55% 148377.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.158M $181.7K
YoY Change 1087.45% 12096.64%
Accrued Expenses $3.789M $5.182M
YoY Change -26.88% 5655.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $16.79M $41.29M
YoY Change -59.34%
Total Short-Term Liabilities $2.158M $276.4K $276.4K
YoY Change 680.82% 44.31% 44.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $46.80M $32.88M
YoY Change 42.36%
Total Long-Term Liabilities $46.80M $32.88M
YoY Change 42.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.158M $276.4K $276.4K
Total Long-Term Liabilities $46.80M $32.88M
Total Liabilities $48.96M $11.35M $33.15M
YoY Change 47.68% 5823.88% 17210.0%
SHAREHOLDERS EQUITY
Retained Earnings $348.7K
YoY Change -16118.19%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $269.8M -$18.30M $285.1M
YoY Change
Total Liabilities & Shareholders Equity $318.8M $318.2M $318.2M
YoY Change 0.17% 148378.55% 148377.17%

Cashflow Statement

Concept 2020 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$19.54M $350.9K
YoY Change -5667.22% -16218.19%
Depreciation, Depletion And Amortization $9.803M $6.897M
YoY Change 42.13%
Cash From Operating Activities -$31.67M -$286.6K
YoY Change 10952.64% 41492.74%
INVESTING ACTIVITIES
Capital Expenditures -$281.0K -$481.0K
YoY Change -41.58%
Acquisitions
YoY Change
Other Investing Activities $713.9K -$316.3M
YoY Change -100.23%
Cash From Investing Activities -$9.770M -$316.3M
YoY Change -96.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.444M 317.6M
YoY Change -98.92% 742772.8%
NET CHANGE
Cash From Operating Activities -$31.67M -286.6K
Cash From Investing Activities -$9.770M -316.3M
Cash From Financing Activities $3.444M 317.6M
Net Change In Cash -$38.00M 1.042M
YoY Change -3748.41% 2376.28%
FREE CASH FLOW
Cash From Operating Activities -$31.67M -$286.6K
Capital Expenditures -$281.0K -$481.0K
Free Cash Flow -$31.39M $194.4K
YoY Change -16246.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
264346
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-3136234
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
181732
CY2020Q4 us-gaap Cash
Cash
399516
CY2019Q4 us-gaap Cash
Cash
1083611
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
90424
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
202472
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
255364
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
CY2020Q4 us-gaap Assets Current
AssetsCurrent
745304
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1286083
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1361
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
318041728
CY2019Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
316958514
CY2020Q4 us-gaap Assets
Assets
318787032
CY2019Q4 us-gaap Assets
Assets
318245958
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2157963
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
94636
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2157963
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
276368
CY2020Q4 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11068750
CY2019Q4 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11068750
CY2020Q4 us-gaap Liabilities
Liabilities
13226713
CY2019Q4 us-gaap Liabilities
Liabilities
11345118
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
300560310
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
301900836
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5990848
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4650349
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-991805
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
348716
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000009
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318787032
CY2020 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
713860
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3447
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1797074
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1339160
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
444168
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1361
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1340521
CY2020Q4 sftwu Marketable Securities Held In Trust
MarketableSecuritiesHeldInTrust
318041728
CY2019 us-gaap Net Income Loss
NetIncomeLoss
350893
CY2020 sftwu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
1793627
CY2020Q4 sftwu Working Capital Deficit
WorkingCapitalDeficit
1627973
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3447
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
40050
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318245958
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1361
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-112048
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
255364
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1976231
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
255364
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
180244
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-94636
CY2020 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3136234
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
350000
CY2020 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
1340526
CY2020 sftwu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
CY2020 sftwu Business Acquisition Percentage Of Minimum Ownership To Be Acquired
BusinessAcquisitionPercentageOfMinimumOwnershipToBeAcquired
0.50
CY2020 sftwu Public Shares Redemption Percentage Threshold
PublicSharesRedemptionPercentageThreshold
0.15
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1397955
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-286574
CY2020 sftwu Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
1.00
CY2020Q4 sftwu Operating Bank Accounts
OperatingBankAccounts
399516
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-264346
CY2020 sftwu Interest Income From Investments Held In Trust Account
InterestIncomeFromInvestmentsHeldInTrustAccount
1793627
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
713860
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
124992
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
571876
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
317578124
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-684095
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1041550
CY2018Q4 us-gaap Cash
Cash
42061
CY2020Q4 sftwu Deposit In The Trust
DepositInTheTrust
1792000
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019 sftwu Proceeds From Sale Of Units Net Of Underwriting Discounts
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscounts
309925000
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8325000
CY2019 sftwu Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
301534750
CY2020Q4 sftwu Gain Loss On Marketable Securities Unrealized
GainLossOnMarketableSecuritiesUnrealized
-7818
CY2019Q4 sftwu Gain Loss On Marketable Securities Unrealized
GainLossOnMarketableSecuritiesUnrealized
1361
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
282584
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1361
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
282584
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1361
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
94636
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-281223
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1361
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
282584
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1361
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93275
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2019 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-366086
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
22823
CY2020 dei Entity Shell Company
EntityShellCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
224992
CY2020 us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
The Sponsor and the Company&#8217;s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation (a) that would modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (b) with respect to any other provision relating to stockholders&#8217; rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
CY2020 us-gaap Revenues
Revenues
0
CY2019 sftwu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
714993
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6479
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1361
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
202472
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
94636
CY2019 sftwu Payments For Investments Of Cash In Trust Account
PaymentsForInvestmentsOfCashInTrustAccount
316250000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-316250000
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 sftwu Sale Of Units Net Of Underwriting Discounts And Value Offering Expenses
SaleOfUnitsNetOfUnderwritingDiscountsAndValueOfferingExpenses
298202124
CY2020 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
1340526
CY2019 sftwu Interest Income From Investments Held In Trust Account
InterestIncomeFromInvestmentsHeldInTrustAccount
714993
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6479
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
708514
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93275
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
29866487
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
30142702
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Registrant Name
EntityRegistrantName
Osprey Technology Acquisition Corp.
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001753539
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2020 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 sftwu Description Of Minimum Votes To Be Polled
DescriptionOfMinimumVotesToBePolled
These provisions of the Company&#8217;s Amended and Restated Certificate of Incorporation may only be amended if approved by holders of a majority of at least 90% of the Company&#8217;s common stock voting in a stockholder meeting.<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8325000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301900836
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
31625000
CY2020 sftwu Number Of Warrant Issued
NumberOfWarrantIssued
8325000
CY2020 sftwu Interest Earned On Marketable Securities Held In Trust Account Of Limited Proportionate
InterestEarnedOnMarketableSecuritiesHeldInTrustAccountOfLimitedProportionate
1693901
CY2019 sftwu Interest Earned On Marketable Securities Held In Trust Account Of Limited Proportionate
InterestEarnedOnMarketableSecuritiesHeldInTrustAccountOfLimitedProportionate
681460
CY2020 sftwu Unrealizedgain Loss On Marketable Securities Held In Trust Account
UnrealizedgainLossOnMarketableSecuritiesHeldInTrustAccount
3255
CY2019 sftwu Unrealizedgain Loss On Marketable Securities Held In Trust Account
UnrealizedgainLossOnMarketableSecuritiesHeldInTrustAccount
-6175
CY2020 sftwu Income From Investments Held In Trust Account Used To Pay For Taxes
IncomeFromInvestmentsHeldInTrustAccountUsedToPayForTaxes
-272467
CY2019 sftwu Income From Investments Held In Trust Account Used To Pay For Taxes
IncomeFromInvestmentsHeldInTrustAccountUsedToPayForTaxes
-200587
CY2020 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1424689
CY2019 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
474698
CY2020 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
22578037
CY2019 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
29584814
CY2020 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0.06
CY2019 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0.02
CY2020 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1424689
CY2019 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
474698
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-2765210
CY2019 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-123805
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9458716
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7591097
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
290402
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.211
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1382869
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
282584
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q2 dei Entity Public Float
EntityPublicFloat
317831250
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Trading Symbol
TradingSymbol
SFTWU
CY2020 dei Security12b Title
Security12bTitle
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant

Files In Submission

Name View Source Status
0001193125-21-100894-index-headers.html Edgar Link pending
0001193125-21-100894-index.html Edgar Link pending
0001193125-21-100894.txt Edgar Link pending
0001193125-21-100894-xbrl.zip Edgar Link pending
d162561d10k.htm Edgar Link pending
d162561dex211.htm Edgar Link pending
d162561dex311.htm Edgar Link pending
d162561dex312.htm Edgar Link pending
d162561dex321.htm Edgar Link pending
d162561dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sftwu-20201231.xml Edgar Link completed
sftwu-20201231.xsd Edgar Link pending
sftwu-20201231_cal.xml Edgar Link unprocessable
sftwu-20201231_def.xml Edgar Link unprocessable
sftwu-20201231_lab.xml Edgar Link unprocessable
sftwu-20201231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending